In 2017, the first review in extenso, written by Dahlberg et al. [43] (in relation to the possible association between the serum levels of vitamin K-dependent proteins and colorectal carcinoma), highlighted the importance of determining subclinical vitamin K deficiency and vitamin K-dependent proteins in association with neoplasia [43]. The gene discussed is PROS1; the disease is colorectal carcinoma.